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According to current critical care management guidelines, the overall hemodynamic optimization process seeks to restore
macrocirculatory oxygenation, pressure, and flow variables. However, there is increasing evidence demonstrating that, despite
normalization of these global parameters, microcirculatory and regional perfusion alterations might occur, and persistence of
these alterations has been associated with worse prognosis. Such observations have led to great interest in testing new technologies
capable of evaluating the microcirculation. Near-infrared spectroscopy (NIRS) measures tissue oxygen saturation (StO
2
) and has
been proposed as a noninvasive system for monitoring regional circulation. The present review aims to summarize the existing
evidence on NIRS and its potential clinical utility in different scenarios of critically ill patients.
1. Introduction
Tissue hypoxia, as results of oxygen supply-demand imbal-
ance at the cellular level, defines circulatory insufficiency
or shock. Maintained over time, this situation might lead
to cellular and organ dysfunction, organ damage, and the
ultimate death of the individual. In our daily clinical practice,
hemodynamic resuscitation of shock states aims to restore
global tissue oxygenationmarkers, such as venous saturations
(either central or mixed) or lactate. Including these endpoint
variables in the management of shock has led to remarkable
improvements in the survival of critically ill patients [1].
However, there is overwhelming evidence demonstrating
that, despite normalization of these global tissue hypoxia
markers, perfusion disorders might persist at themicrocircu-
latory level [2, 3]. Importantly, persistence of these alterations
has been independently associated with further development
of multiple organ failure (MOF) and poor outcome [4, 5].
Consequently, over the last years there has been growing
interest in developing new technologies capable of assessing
the regional circulation and/or the microcirculation [6, 7].
Evaluating the microcirculation in the critically ill
patients has been associated with more than a few technical
problems, which have delayed their use at the bedside. In
addition to the technical limitations, a clinically relevant
issue has been finding the right place to monitor. Since any
used technology can only assess the microvascular bed of
a given sampled tissue, it is necessary to choose accessible
territories and yet sufficiently representative of the whole
body wellness. Currently, there are several technologies
available for the evaluation of themicrocirculation [6], which
can be classified into two main groups: (a) firstly, direct
methods, which allow the visualization of the microvascular
bed (such as videomicroscopy); and (b) secondly, indirect
methods based on measures of tissue oxygenation, as surro-
gates of microcirculatory perfusion. In the latter group we
can include technologies such as gastric tonometry, tissue
oxygen electrodes, sublingual capnometry, and near-infrared
spectroscopy (NIRS). Due to its noninvasive nature and its
easy applicability, NIRS technology has aroused increasing
interest in the evaluation of the regional circulation. This
review aims to summarize what, today, has shown this
technology in the field of the critically ill patients.
2. Near-Infrared Spectroscopy (NIRS):
Basic Principles
The concept of NIRS technology has already been available
for many decades, and it has been developed for different
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purposes, ranging from chemical analysis in agriculture to
pharmaceutical and medical applications. In the late seven-
ties, first noninvasive NIRS devices were used to monitor
cerebral and myocardial oxygenation status in living tissues
[8], suggesting that the NIRS spectrum of light was perfectly
suited for monitoring in vivo tissue oxygen provision and
utilization. Since then, many studies in humans, along with
the development of portable, noninvasive NIRS systems,
account for the growing interest in this technology [9, 10].
NIRS technology is based on measuring the attenuation
of light in the near-infrared spectrum (700–1000 nm wave-
lengths) to measure the chromophores, mainly hemoglobin,
present in the sampled tissue. Although many other chro-
mophores can influence the obtained NIRS signal (such as
bilirubin, melanin, myoglobin, and cytochrome a,a3), choos-
ing specific wavelengths allows for minimizing the impact of
these substances, and the obtained signal is derived mainly
from oxy- and deoxyhemoglobin. The equipment required
for an NIRS system consists of a light source, optical bundles
(optodes) for light emission and reception, a processor, and
a display system [9]. The distance between the point of
light entry and exit (optode separation) will determine the
magnitude of sampled tissue. The NIRS signal is derived
mainly from the hemoglobin contained in the entire vascular
tree and mainly small vessels (arterioles, capillaries, and
venules) present in the sampled area [9–13]. Finally, oxy- and
deoxyhemoglobin measures permit calculating the overall
saturation for tissue hemoglobin or tissue oxygen saturation
(StO
2
) [13]. NIRS systems can also provide an estimation of
the amount of hemoglobin contained in the sampled area,




has been evaluated in several organs
(brain, kidney, and liver), for resuscitation purposes, skeletal
muscle StO
2
, due to its nonvital peripheral organ condi-
tion, has emerged as a potential early detector of occult
hypoperfusion. This review will focus on the usefulness of
StO
2
derived from skeletal muscle in the critical patient.
Several muscle locations have been used in the critical care
setting. Since StO
2
measurements derived from the NIRS
signal might be altered by local factors such as edema and
adipose tissue thickness, some authors have proposed the
thenar eminence as a reliable site, less subject to inter- and
intraindividual variabilities [13, 14]. Although the thenar
eminence is the most widely tested area, interesting results
have been obtained also when measuring StO
2
on muscle
locations, such as masseter, deltoid, and the knee area [15,
16]. In healthy basal conditions, the NIRS signal reflects
predominantly the venous oxygenation, since an estimated
75% of the blood present in the skeletal muscle is located in
the venous compartment [9]. In 700 healthy volunteers, the
baseline StO
2
value measured in the thenar eminence was
87% ± 6% [17]. Similar to mixed venous oxygen saturation,
StO
2
reflects the balance between local oxygen supply and
consumption, and any measured change in StO
2
could be
interpreted in both directions: changes in local microcircu-
latory flow and/or changes in local consumption. Moreover,
inversely proportional changes in local flow and consumption
could lead to relatively stable values of StO
2
[6].
3. Vascular Occlusion Test (VOT)
In addition to monitoring the absolute StO
2
value in the
thenar eminence, the StO
2
response to a brief ischemic
challenge has been explored, in order to obtain dynamic
information on tissue performance. The so-called vascular
occlusion test (VOT) consists in executing an arterial occlu-
sion, proximal to the StO
2
probe (usually by means of a
tourniquet system on the forearm), until a given ischemic
threshold is reached, and then the occlusion is released. This
test allows generating some dynamic parameters and spe-
cially the initial Hb deoxygenation slope (or DeO
2
; expressed
as % over time) in the phase of ischemia, followed by the Hb
reoxygenation slope (or ReO
2
; also expressed in % over time)
once the vascular occlusion is released (Figure 1).
Since DeO
2
represents the progressive Hb desaturation
in a zero-flow situation, it has been proposed as a marker of
local oxygen extraction. Correcting the DeO
2
slope for the
estimated local amount of Hb derives a parameter of local
oxygen consumption, expressed as nirVO
2
, as proposed by





On the other hand, ReO
2
reflects the Hb resaturation, and
this will directly depend on blood inflow and capillary
recruitment after the hypoxic stimulus. ReO
2
has been named
as a reflection of endothelial function; however, several
observations have also correlated ReO
2
to perfusion pressure
[23, 24], and, thus, the resulting ReO
2
seems to be derived
from the interaction of perfusion pressure and endothelial
integrity. In its recovery, absolute StO
2
may temporarily raise
the above previous baseline values, indicating postischemic
vasodilation and capillary recruitment, also known as reac-
tive hyperemia (Figure 1).
Different VOTmethodologies have been described, some
of them aimed at maintaining a fixed time of ischemia (3–5
minutes), and some of them sought for an ischemic threshold
(StO
2
drops until a specific value).The lack of standardization
of the VOT has led to great difficulties when trying to
compare results from different studies. This fundamental
issue represents an important limitation of the test, alongwith
the variety of sampled depths and sites used to measure the
StO
2
response to ischemia [14, 25]. According to the existing
literature [14, 25], maintaining the ischemic stimulus until a
determined StO
2
value is achieved seems to minimize inter-
individual variations, thus homogenizing ReO
2
values for
their comparison. Future consensus should also be applied to
the location and depth of measurement of StO
2
[14].
4. StO2 in the Critically Ill Patients
While the NIRS technology was developed several decades
ago, the newnoninvasive andportableNIRS systems emerged
as an attractive technology for early detection of shock states
in armed conflicts. Thus, initial efforts addressed mainly the
value of these systems in hypovolemic shock. After some
promising results, NIRS was also explored in other critical
conditions and particularly in septic shock.
4.1. StO
2
in Hypovolemic Shock. In low blood flow states
secondary to hypovolemia (such as hemorrhagic shock)
























response to a vascular occlusion test (VOT). The
transient ischemia generates two main parameters: the deoxygena-
tion response (DeO
2
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the activation of the sympathetic nervous system causes
blood flow redistribution from the periphery to the central
compartment, through vasoconstriction in certain territories,
in order to maintain an optimal perfusion of vital organs
[26]. This compensatory mechanism can mask significant
hypovolemia associated with hypoperfusion in certain ter-
ritories, with significant negative impact on outcome [1].
Accordingly, in situations of hypovolemia, a decrease in blood
flow to skeletal muscle is expected, with increases in oxygen
extraction and decreases in the content of hemoglobin at the
regional level. Thus, hypothetically, the evaluation of periph-
eral perfusion by using StO
2
seems highly interesting as an
early marker of tissue hypoperfusion caused by hypovolemia
[27].
This hypothesis was initially tested in experimental con-
ditions, in animal models of hemorrhagic shock. First obser-
vations correlated StO
2
to global variables of flow and oxygen
delivery [28–30], suggesting that regional oxygenation mea-
sured by NIRS would be able to noninvasively detect progres-
sive hypovolemia. Crookes et al. [31], in a prospective model
of resuscitation from hemorrhagic shock, concluded that
StO
2
was a better discriminator for survivors to hemorrhage
than mixed venous oxygen saturation (SvO
2
), blood lactate,
and base deficit. In human models of central hypovolemia in
healthy subjects, StO
2
and the tissue hemoglobin index (THI)
fall have been shown to detect decreases in blood volume
equivalent to 400–500 cc, even before the onset of tachycardia
or hypotension [32–34]. In addition to its ability to detect
progressive hypovolemia, StO
2
has also been tested for its
utility in guiding intravascular volume optimization. On that
behalf, Cohn et al., in a prospective randomized pilot study
in patients undergoing elective colorectal surgery, analyzed
the impact of a standard versus restrictive fluid approach on
tissue oxygenation and development of complications [35].
The authors concluded that the restrictive approach was not
associatedwith lower StO
2
values, suggesting that StO
2
would
be a useful parameter for guiding fluid administration during
surgery, ensuring tissue wellness, and avoiding unnecessary
fluid overload, which has repeatedly been associated to higher
morbidity derived from surgery [36, 37].
In trauma patients, StO
2
correlation to parameters of flow
and oxygen delivery has been also verified [38]. Furthermore,
the absolute value of StO
2
has repeatedly demonstrated
its prognostic value in this patient population. Low StO
2
values during the initial approach to these patients have
been associated with larger transfusion requirements [39–
41], increased risk of infection [42], multiorgan failure [42,
43], and even higher mortality rates [43, 44]. Importantly,
this predictive value was maintained in apparently stable
hemodynamic conditions (defined as systolic blood pressure
> 90mmHg) [40, 41]. In addition to absolute StO
2
values,
dynamic variables derived from the VOT have also shown
their prognosis in trauma patients [45, 46]. In a recent
publication, Guyette et al. [45] demonstrated that early
alterations in DeO
2
were independently associated with the
need for early interventions (red blood cell transfusion,
emergent surgery, etc.). In this observational study, DeO
2
was superior to absolute StO
2
for predictive purposes. Once
again, this association was independent and more sensitive
than other physiological variables, such as heart rate or
blood pressure. Despite the cumulative evidence on the
prognostic value of StO
2
in trauma, with its potential use
for early identification of at-risk patients, to this day, there
is a lack of prospective studies exploring the usefulness of
StO
2
in trauma resuscitation algorithms, either as a trigger for




in Severe Sepsis and Septic Shock. The value of
StO
2
has been also widely explored in patients with severe
sepsis and septic shock. While absolute StO
2
values have
shown robust prognostic implications in trauma patients, in
septic conditions this association appears to bemore complex
[15, 47, 48]. Although septic patients tend to show lower
StO
2
values than healthy subjects, there is a huge overlap
between these populations [19]. These observations could be
derived from the heterogeneous nature of microcirculatory
alterations in sepsis (ischemic and highly oxygenated coexist-
ing areas), with an overall “normal” oxygen content in a given
sensed area [27]. The low sensitivity for these conditions





VOT-derived variables have yielded much




Several authors have reported alterations in the StO
2
response to the VOT in sepsis, and the magnitude of such
alteration has been directly correlated with the development
of organ failure, ICU length of stay, or even mortality [15,
18, 20, 23, 49] (Table 1). Alterations in DeO
2
, represented by
lower deoxygenation rates, have been associated with poor
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prognosis. Since DeO
2
reflects local oxygen consumption, it
seems reasonable to hypothesize that patients with limited
oxygen extractionwill develop higher degrees of organ failure
[18, 23]. This local oxygen consumption limitation may be
due to two different but cumulative mechanisms: (a) a local
supply-demand dependency on low flow or inadequate flow
conditions or (b) a low oxygen extraction at the cellular
level due to mitochondrial dysfunction and/or alteration of
oxygen diffusion (interstitial edema) [23, 50]. Regrettably,
the NIRS technology is unable to determine which of these
two mechanisms presents greater contribution to the final
DeO
2
. Regarding the ReO
2
slope, it is also diminished in
septic patients when compared to healthy subjects [19, 20,
22, 23, 48]. Moreover, the magnitude of ReO
2
decreased
slope has also been correlated to the severity of the episode,
and some studies have even demonstrated association with
mortality [19, 22, 48]. Not only the initial ReO
2
value but the
persistence of alterations in ReO
2
during resuscitation has
been associated with worse prognosis [19].
5. Adding StO2 to Current
Resuscitation Algorithms?
Although, as we have exposed, StO
2
has consistently demon-
strated its prognostic value in critically ill patients, there is
still so much to explore in terms of its clinical applicability at
the bedside. One of the major issues that needs to be faced
is where to incorporate StO
2
in hemodynamic resuscitation
algorithms and, of course, testing whether StO
2
incorpora-
tion is associated with improvement in outcomes.
5.1. Early. Due to its condition of noninvasive continuous
measurement of regional oxygenation status, StO
2
was ini-
tially explored in its ability to early detect hypoperfusion,
and previously to monitor parameters that require invasive
procedures or laboratory analysis. Some authors explored the
correlation of StO
2
with parameters of global oxygenation,
such as central venous oxygen saturation (ScvO
2
) [51–55],





when measured on the thenar eminence) specifically predict
extremely low ScvO
2
values [15, 51, 52]. However, the sen-
sitivity of StO
2
variables to detect these situations of global
hypoperfusion is considerably low, and therefore the absolute
StO
2
value has been proposed as an initial tool to rapidly
and noninvasively detect hypoperfusion states, but only while
other more sensitive variables are not available [23, 51, 52]. In
conclusion, in situations of apparent hemodynamic stability
in which we do not have invasive oxygenation parameters,
NIRS-derived variables might be useful in the detection of
at-risk patients, justifying the need for the beginning of the
reanimation process, as well as a more aggressive monitoring
[45, 51].
5.2. Late. Cumulative evidence on the association between
microcirculatory alterations persistence, despite normaliza-
tion of macrohemodynamic variables, and poor prognosis
[1] has led to the idea that evaluating regional oxygenation
parameters should be performed at the end of conventional
“global” resuscitation. In addition to several in vivo videomi-
croscopy studies, Lima et al. recently found, in a population
of septic patients, that alterations in StO
2
values at the end
of the Early Goal-Directed Therapy (EGDT) were associated
with higher degrees of organ failure and mortality [16].
Some other studies have also shown consistent data regarding
StO
2
parameters and prognosis despite macrohemodynamic
normalization [16, 23]. Unfortunately and once again, there
is a lack of prospective interventional studies analyzing the
usefulness of adding StO
2
to the resuscitation algorithm.The
fact that whether StO
2
might be used instead of or comple-
mentary to current global tissue oxygenation endpoints, such
as ScvO
2
and lactate, deserves further investigation. In a small
pilot study, Nardi et al. [56] attempted to incorporate the StO
2
measured at three different locations as an endpoint parame-
ter for resuscitation in septic patients. In their protocol, once
ScvO
2
values were normalized according to the Surviving
Sepsis Campaign guidelines, StO
2
goals were pursued in
the treatment group. The authors found no benefit in the
inclusion of StO
2
in the resuscitation algorithm. However,
the small sample size, the use of the absolute value of StO
2




), and the fact
that a large percentage of patients in the treatment group did
not even normalize the endpoint ScvO
2
valuesmight account
for the lack of differences observed in the evolution of the
patients.
One might conclude that prospective studies are needed
to evaluate the usefulness of adding StO
2
to our current
macrohemodynamic approach to resuscitation. This major
limitation would be applied, to date, to every single regional
or microcirculatory monitoring system.
6. Further StO2 Applications in Intensive Care
In addition to its potential application in shock states, the
StO
2
may have utility in other clinical scenarios in critical
care. Continuous StO
2
monitoring has shown encouraging
results in cardiovascular performance challenges, as in wean-
ing from mechanical ventilation [57]. In a recent study, our
group noted that changes in DeO
2
within a 30-minute spon-
taneous breathing trial discriminated patients who would
succeed in from those who would fail the disconnection
from mechanical ventilation process [57], supporting the
role of StO
2
as a monitoring system for detecting limited
cardiovascular reserve.
7. Technology Limitations
Several limiting factors deserve mention, as they might
interfere in StO
2
values and/or interpretation [58, 59]: (a)
exogenous factors, such as changes in environment tempera-
ture; (b) endogenous factors such as age, obesity, body tem-
perature, tissue edema, vascular diseases, and agitation; (c)
drugs that modify vascular tone [24].We already commented
on the fact that the heterogeneous nature of microcirculatory
alterations in septic shock might limit the value of some of
the data obtained using the NIRS technology [27]. Finally,
it is important to account for an important consideration
6 BioMed Research International
about this technique: NIRS is a relatively new technology
for monitoring the regional circulation in critical care, where
no “gold standard” has been validated. However, instead
of representing a limitation, the latter might stand for an
“everything needs to be done” in regional perfusion and




and its dynamic variables derived from
the VOT have demonstrated their prognostic value in several
critical scenarios. The lack of randomized controlled trials
analyzing their inclusion in the resuscitation process is the
main constraint to the use of this technology at the present
time. In addition to its potential value in resuscitation, StO
2
variables might be useful in other clinical settings, where
cardiovascular performance needs to be challenged, such as
weaning from mechanical ventilation.
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